Navigation Links
Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
Date:12/5/2012

Research Triangle Park, NC (PRWEB) December 05, 2012

Soybean growers in the Midwest continue to struggle with sudden death syndrome (SDS), which was discovered in 1971. According to the Plant Heatlh Initiative, SDS is now considered one of the top four yield-robbing diseases in soybean and appears to be spreading. The disease is capable of devastating soybean fields, affecting some growers’ entire soybean crops and significantly reducing their yield even up to 90 percent in some years.

Bayer CropScience SeedGrowth™ (formerly Seed Treatment) is studying a product it believes will combat SDS and give growers a much-needed solution to this problem. This new product is a seed treatment that is applied directly to soybean seed and helps to control the Fusarium fungus that causes SDS.

“Sudden death syndrome often doesn’t show symptoms in the soybeans until it is too late for the grower to help their crop,” said Ethan Luth, SeedGrowth product manager at Bayer CropScience, “We know growers are frustrated with SDS, and until now, there hasn’t been a complete solution. However, trials of our new product are showing promising results, and we believe it will help growers to prevent losses from SDS.”

The fungal pathogen that causes SDS favors cool, moist growing conditions for infection. During soybeans’ early development stages, the infection invades the root system, but there are no visible symptoms until after flowering, at which time there are no known treatment options. The fungal infection suddenly becomes obvious as leaves display intervenial yellowing and necrosis, resulting in leaf drop during the critical stage of pod filling and effecting yield potential.

“When managing Sudden Death Syndrome, it is important to utilize an
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
2. Bayer Bee Care Center Helps Solve Bee Health’s Toughest Challenges
3. Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
4. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
5. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
6. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
7. Organovo Reports Q3 2012 Financial Results, Provides Business Update
8. Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012
10. Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update
11. Life Technologies New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 21, 2014 2014 Deep ... professional and in-depth research report on the transformer ... definition, classification, application, and industry chain structure as ... international market analysis, including China’s domestic market as ... & economic situation analysis. The report also covers ...
(Date:11/21/2014)... /CNW/ - Aequus Pharmaceuticals Inc. (the "Company" or ... closed a brokered private placement offering (the "Brokered ... Cormark Securities Inc. and Clarus Securities Inc. acted ... a syndicate of agents that also included Wolverton ... "Agents"). Concurrently with the Brokered Offering, the Company ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... nine month periods ended September 30, 2014.  Biorem,s complete 2014 third ... www.sedar.com ). Financial Summary:Three-months ended September 30, ... per share data) , 2014 , 2013 ... 2,282 , 5,281 , 6,715 , ...
(Date:11/18/2014)... 17, 2014 RPS Diagnostics (RPS®) ... – today announces its third annual partnership of ... Get Smart About Antibiotics Week from November 17-23. ... national campaign designed to highlight the coordinated efforts ... non-profit and for-profit partners to provide education about ...
Breaking Biology Technology:International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3
... BEIJING, June 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE ... of vaccines in China, announced today that,China,s Vice Premier, ... State Council, Ma Kai; Head of General Administration of,Quality ... Health, Chen Zhu; Vice Minister of Ministry of Science ...
... , NEW YORK, June 2 Delcath Systems, Inc. ... testing its proprietary treatment method for primary and metastatic ... States Food and Drug Administration ("FDA") granted Delcath,s application ... treatment of patients with neuroendocrine tumors. , , ...
... MOUNTAIN VIEW, Calif., June 2 VIVUS, Inc. (Nasdaq: ... next-generation therapies to address unmet needs in obesity, diabetes ... be featured in two podium presentations during the 69th ... held from June 5-9, 2009 in New Orleans, Louisiana. ...
Cached Biology Technology:China's Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation 2China's Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation 3Delcath Systems Granted Third Orphan Drug Designation 2Delcath Systems Granted Third Orphan Drug Designation 3Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting 2Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting 3
(Date:11/4/2014)... amount of death at the right time might actually ... research that could help in understanding animal populations, pest ... a paper in the journal Trends in Ecology ... colleagues conclude that the kind of positive population effect ... or mortality, depends on the size and developmental stage ...
(Date:11/4/2014)... 2014   3D ... Fuel3D , a developer of 3D scanning ... totaling $6.4 million (£4 million). This funding builds on the ... year and paves the way for the commercial launch of ... funding round was led by Chimera Partners and will be ...
(Date:11/3/2014)... published in this month,s Proceedings of the ... a recently discovered communication molecule of the body,s immune ... to limit inflammation and the current study reports its ... ability of the immune system to recognize and target ... effect on the immune system now allows us to ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3PNAS: From HIV to cancer, IL-37 regulates immune system 2
... -- Microbes living at the bottom of the Gulf of ... the Deepwater Horizon oil spill than previously thought, according to ... A paper on that research, conducted before the Deepwater ... a forthcoming issue of the journal Deep-Sea Research II ...
... cells live ever on the verge of suicide, requiring ... prevent the cells from pulling the trigger. This self-destructive ... dangerous precancerous cells are permitted to kill themselves, but ... that store memories, for instance. Rockefeller University scientists are ...
... [Brown University] Living with HIV is difficult under ... virus, alcohol consumption can become particularly perilous in intricate ... the Brown Alcohol Research Center on HIV (ARCH) funded ... Institutes of Health, Brown University scientists will study the ...
Cached Biology News:Microbes may consume far more oil-spill waste than earlier thought 2'Reaper' protein strikes at mitochondria to kill cells 2$7.5M grant to fund research on interaction of drinking and HIV infection 2$7.5M grant to fund research on interaction of drinking and HIV infection 3
Collected from animals that are 16 to 18 months old. Sterile, Cell culture tested, ID clarifier: USA Origin...
... a cytochrome P450 (CYP450) metabolite postulated to ... and cerebral vasculature. In rat cerebral microvessels, ... autoregulatory vasoconstriction. 20-HETE is excreted mainly as ... 20-HETE (20-40 pg/ml in human urine) is ...
... enables you to insert a transposable element ... by in vitro transposition. It uses TnsABC* ... the DNA target. Target DNA may be ... depending on your interests (6-8). If the ...
A set of five peptides which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
Biology Products: